Cargando…

Clinical Relevance of the Tumor Location-Modified Laurén Classification System for Gastric Cancer in a Western Population

BACKGROUND: The Tumor Location-Modified Laurén Classification (MLC) system combines Laurén histologic subtype and anatomic tumor location. It divides gastric tumors into proximal non-diffuse (PND), distal non-diffuse (DND), and diffuse (D) types. The optimum classification of patients with Laurén mi...

Descripción completa

Detalles Bibliográficos
Autores principales: Moore, J. L., Davies, A. R., Santaolalla, A., Van Hemelrijck, M., Maisey, N., Lagergren, J., Gossage, J. A., Kelly, M., Baker, C. R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9072452/
https://www.ncbi.nlm.nih.gov/pubmed/35041098
http://dx.doi.org/10.1245/s10434-021-11252-y
_version_ 1784701064593801216
author Moore, J. L.
Davies, A. R.
Santaolalla, A.
Van Hemelrijck, M.
Maisey, N.
Lagergren, J.
Gossage, J. A.
Kelly, M.
Baker, C. R.
author_facet Moore, J. L.
Davies, A. R.
Santaolalla, A.
Van Hemelrijck, M.
Maisey, N.
Lagergren, J.
Gossage, J. A.
Kelly, M.
Baker, C. R.
author_sort Moore, J. L.
collection PubMed
description BACKGROUND: The Tumor Location-Modified Laurén Classification (MLC) system combines Laurén histologic subtype and anatomic tumor location. It divides gastric tumors into proximal non-diffuse (PND), distal non-diffuse (DND), and diffuse (D) types. The optimum classification of patients with Laurén mixed tumors in this system is not clear due to its grouping with both diffuse and non-diffuse types in previous studies. The clinical relevance of the MLC in a Western population has not been examined. METHODS: A cohort study investigated 404 patients who underwent gastrectomy for gastric adenocarcinoma between 2005 and 2020. The classification of Laurén mixed tumors was evaluated using receiver operating characteristic (ROC) curve analysis and comparison of clinicopathologic characteristics (chi-square). Survival analysis was performed using multivariable Cox regression. RESULTS: The ROC curve analysis demonstrated a slightly higher area under the curve value for predicting survival when Laurén mixed tumors were grouped with intestinal-type rather than diffuse-type tumors (0.58 vs 0.57). Survival, tumor recurrence, and resection margin positivity in mixed tumors also was more similar to intestinal type. Distal non-diffuse tumors had the best 5-year survival (DND 64.7 % vs PND 56.1 % vs diffuse 45.1 %; p = 0.006) and were least likely to have recurrence (DND 27.0 % vs PND 34.3 % vs diffuse 48.3 %; p = 0.001). Multivariable analysis demonstrated that MLC was an independent prognostic factor for survival (PND: hazard ratio [HR], 1.64; 95 % confidence interval [CI], 1.16–2.32 vs diffuse: HR, 2.20; 95 % CI, 1.56–3.09) CONCLUSIONS: The MLC was an independent prognostic marker in this Western cohort of patients with gastric adenocarcinoma. The patients with PND and D tumors had worse survival than those with DND tumors. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1245/s10434-021-11252-y.
format Online
Article
Text
id pubmed-9072452
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Springer International Publishing
record_format MEDLINE/PubMed
spelling pubmed-90724522022-05-07 Clinical Relevance of the Tumor Location-Modified Laurén Classification System for Gastric Cancer in a Western Population Moore, J. L. Davies, A. R. Santaolalla, A. Van Hemelrijck, M. Maisey, N. Lagergren, J. Gossage, J. A. Kelly, M. Baker, C. R. Ann Surg Oncol Gastrointestinal Oncology BACKGROUND: The Tumor Location-Modified Laurén Classification (MLC) system combines Laurén histologic subtype and anatomic tumor location. It divides gastric tumors into proximal non-diffuse (PND), distal non-diffuse (DND), and diffuse (D) types. The optimum classification of patients with Laurén mixed tumors in this system is not clear due to its grouping with both diffuse and non-diffuse types in previous studies. The clinical relevance of the MLC in a Western population has not been examined. METHODS: A cohort study investigated 404 patients who underwent gastrectomy for gastric adenocarcinoma between 2005 and 2020. The classification of Laurén mixed tumors was evaluated using receiver operating characteristic (ROC) curve analysis and comparison of clinicopathologic characteristics (chi-square). Survival analysis was performed using multivariable Cox regression. RESULTS: The ROC curve analysis demonstrated a slightly higher area under the curve value for predicting survival when Laurén mixed tumors were grouped with intestinal-type rather than diffuse-type tumors (0.58 vs 0.57). Survival, tumor recurrence, and resection margin positivity in mixed tumors also was more similar to intestinal type. Distal non-diffuse tumors had the best 5-year survival (DND 64.7 % vs PND 56.1 % vs diffuse 45.1 %; p = 0.006) and were least likely to have recurrence (DND 27.0 % vs PND 34.3 % vs diffuse 48.3 %; p = 0.001). Multivariable analysis demonstrated that MLC was an independent prognostic factor for survival (PND: hazard ratio [HR], 1.64; 95 % confidence interval [CI], 1.16–2.32 vs diffuse: HR, 2.20; 95 % CI, 1.56–3.09) CONCLUSIONS: The MLC was an independent prognostic marker in this Western cohort of patients with gastric adenocarcinoma. The patients with PND and D tumors had worse survival than those with DND tumors. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1245/s10434-021-11252-y. Springer International Publishing 2022-01-18 2022 /pmc/articles/PMC9072452/ /pubmed/35041098 http://dx.doi.org/10.1245/s10434-021-11252-y Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Gastrointestinal Oncology
Moore, J. L.
Davies, A. R.
Santaolalla, A.
Van Hemelrijck, M.
Maisey, N.
Lagergren, J.
Gossage, J. A.
Kelly, M.
Baker, C. R.
Clinical Relevance of the Tumor Location-Modified Laurén Classification System for Gastric Cancer in a Western Population
title Clinical Relevance of the Tumor Location-Modified Laurén Classification System for Gastric Cancer in a Western Population
title_full Clinical Relevance of the Tumor Location-Modified Laurén Classification System for Gastric Cancer in a Western Population
title_fullStr Clinical Relevance of the Tumor Location-Modified Laurén Classification System for Gastric Cancer in a Western Population
title_full_unstemmed Clinical Relevance of the Tumor Location-Modified Laurén Classification System for Gastric Cancer in a Western Population
title_short Clinical Relevance of the Tumor Location-Modified Laurén Classification System for Gastric Cancer in a Western Population
title_sort clinical relevance of the tumor location-modified laurén classification system for gastric cancer in a western population
topic Gastrointestinal Oncology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9072452/
https://www.ncbi.nlm.nih.gov/pubmed/35041098
http://dx.doi.org/10.1245/s10434-021-11252-y
work_keys_str_mv AT moorejl clinicalrelevanceofthetumorlocationmodifiedlaurenclassificationsystemforgastriccancerinawesternpopulation
AT daviesar clinicalrelevanceofthetumorlocationmodifiedlaurenclassificationsystemforgastriccancerinawesternpopulation
AT santaolallaa clinicalrelevanceofthetumorlocationmodifiedlaurenclassificationsystemforgastriccancerinawesternpopulation
AT vanhemelrijckm clinicalrelevanceofthetumorlocationmodifiedlaurenclassificationsystemforgastriccancerinawesternpopulation
AT maiseyn clinicalrelevanceofthetumorlocationmodifiedlaurenclassificationsystemforgastriccancerinawesternpopulation
AT lagergrenj clinicalrelevanceofthetumorlocationmodifiedlaurenclassificationsystemforgastriccancerinawesternpopulation
AT gossageja clinicalrelevanceofthetumorlocationmodifiedlaurenclassificationsystemforgastriccancerinawesternpopulation
AT kellym clinicalrelevanceofthetumorlocationmodifiedlaurenclassificationsystemforgastriccancerinawesternpopulation
AT bakercr clinicalrelevanceofthetumorlocationmodifiedlaurenclassificationsystemforgastriccancerinawesternpopulation
AT clinicalrelevanceofthetumorlocationmodifiedlaurenclassificationsystemforgastriccancerinawesternpopulation